Evidence map›Paper›PMID 35423050›Full record

ArticleRSC advances2020

Synthetic- and DFT modelling studies on regioselective modified Mannich reactions of hydroxy-KYNA derivatives.

Bálint Lőrinczi, Antal Csámpai, Ferenc Fülöp, István Szatmári

Abstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Synthesis and Transformation of Tricyclic KYNA Derivatives.International journal of molecular sciences · 2025
    Article
  3. Article
  4. RSC advances · 2024
    Article
  5. Formation of 5-Aminomethyl-2,3-dihydropyridine-4(1Molecules (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Synthesis of 4-Hydroxyquinolines as Potential Cytotoxic Agents.International journal of molecular sciences · 2022
    Article
  8. Article
  9. Synthesis of quinolinesRSC advances · 2021
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bálint LőrincziInstitute of Pharmaceutical Chemistry and Research Group for Stereochemistry, Hungarian Academy of Sciences, University of Szeged H-6720 Szeged Eötvös u. 6 Hungary lorinczi.balint@pharm.u-szeged.hu fulop@pharm.u-szeged.hu szatmari.istvan@pharm.u-szeged.hu +36-62-341-966.ORCID https://orcid.org/0000-0001-7773-0034
Antal CsámpaiDepartment of Inorganic Chemistry, Eötvös Loránd University (ELTE) Pázmány P. sétány 1/A H-1117 Budapest Hungary csampai@caesar.elte.hu.
Ferenc FülöpInstitute of Pharmaceutical Chemistry and Research Group for Stereochemistry, Hungarian Academy of Sciences, University of Szeged H-6720 Szeged Eötvös u. 6 Hungary lorinczi.balint@pharm.u-szeged.hu fulop@pharm.u-szeged.hu szatmari.istvan@pharm.u-szeged.hu +36-62-341-966.
István SzatmáriInstitute of Pharmaceutical Chemistry and Research Group for Stereochemistry, Hungarian Academy of Sciences, University of Szeged H-6720 Szeged Eötvös u. 6 Hungary lorinczi.balint@pharm.u-szeged.hu fulop@pharm.u-szeged.hu szatmari.istvan@pharm.u-szeged.hu +36-62-341-966.ORCID https://orcid.org/0000-0002-8571-5229

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The syntheses of hydroxy-substituted kynurenic acid (KYNA) derivatives have been achieved by an optimised Conrad-Limpach procedure. The derivatives were then reacted with morpholine and paraformaldehyde, as a representative amine and aldehyde, in a modified Mannich reaction. The newly introduced substituents altered the preferred reaction centre of the KYNA skeleton. A systematic investigation of substitutions was carried out, using different reaction conditions, resulting in mono- or disubstituted derivatives. Product selectivity and regioselectivity were rationalised by DFT calculations disclosing HOMO distribution and NBO charges on the potential nucleophilic centres in the anion of the appropriate KYNA ester assumed to be active components towards the iminium ion intermediate.

Identifiers

PMID35423050
PMCPMC8691111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.